FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to endocrinology and concerns treatment of type 2 diabetes mellitus. That is ensured by simultaneous administration of the preparations of the groups: metformin, sulphonylurea, glitazone and incretin in the developed regimens and dosages.
EFFECT: method provides higher clinical effectiveness and reduced time of treatment, and less by-effects due to involvement of all the links of pathogenesis of type 2 diabetes mellitus.
1 ex, 1 tbl
Authors
Dates
2010-09-10—Published
2009-05-18—Filed